Chandra Bhagat Pharma Limited has issued a corrigendum to its Notice of the Annual General Meeting (AGM) originally dispatched to shareholders on 6th August 2026. The AGM is scheduled to be held on Tuesday, 1st September 2026 at 04:00 P.M. (IST) at the company's Registered Office at 323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai-400019, Maharashtra, India.
The corrigendum was issued pursuant to a request from BSE Limited under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The stock exchange required the company to provide the exact web link to the compliance certificate issued by M/s. Dilip Swarnkar & Associates, Practicing Company Secretary, regarding the proposed preferential issue.
The company is seeking shareholder approval for the issuance of 66,00,000 (Sixty-Six Lakhs) Convertible Warrants on a preferential basis, as detailed in Item No. 4 of the Explanatory Statement to the AGM Notice. The corrigendum specifically updates sub-item No. 19 under Item No. 4 to include the web link where the compliance certificate can be accessed: https://cbcpharma.com/wp-content/uploads/2026/08/CS-Certificate.pdf
The certificate confirms that the preferential allotment is being made in accordance with the requirements contained in the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.
The corrigendum was sent to shareholders via email on 20th August 2026 through MUFG Intime India Private Limited (formerly Link Intime India Private Limited) and has been made available on the BSE website. It forms an integral part of the original AGM notice. All other contents of the AGM notice and explanatory statement remain unchanged except for this modification.
M/s. Amit Dharmani & Associates, Practicing Company Secretaries, will act as the Scrutinizer for the voting process. The corrigendum was digitally signed by Hemant Chandravadan Bhagat, Managing Director (DIN: 00233530), on behalf of the company.